The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 

"Prasugrel provided the optimal balance between efficacy and safety," researchers noted in a new meta-analysis. 

The new AI-enabled resource works like a search engine and delivers answers in seconds.

A total of 24 adverse safety incidents—including cases of diabetic ketoacidosis—have been linked to this issue.

However, no significant difference was seen in heart failure hospitalization rates. The study's authors emphasized that more research on this topic is still necessary. 

Physicians from all specialties, not just cardiology, have been hoping for legislation like this for years.

Researchers explored data from nearly 800 patients, focusing on a wide variety of outcomes.

Devi Nair, MD, spoke to Cardiovascular Business about her own experience using concomitant LAA occlusion as an add-on to catheter ablation procedures.

This is a Class I recall, according to the FDA. Care teams may need to send in their equipment so that specific hardware updates can be performed.

The issue at the heart of this recall has been linked to three patient deaths.